Jpmorgan Chase & CO Lisata Therapeutics, Inc. Comm Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Lisata Therapeutics, Inc. Comm stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13 shares of LSTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 15 13.33%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
N/A
-2 Reduced 13.33%
13 $0
Q3 2024

Dec 26, 2024
SELL
N/A
-1 Reduced 6.25%
15 $0
Q3 2024

Nov 08, 2024
SELL
N/A
-1 Reduced 6.25%
15 $0
Q2 2024

Dec 26, 2024
BUY
N/A
1 Added 6.67%
16 $0
Q1 2024

Dec 26, 2024
BUY
N/A
1 Added 6.67%
16 $0
Q1 2024

May 10, 2024
BUY
N/A
5 Added 45.45%
16 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-4 Reduced 26.67%
11 $0
Q4 2023

Feb 12, 2024
BUY
N/A
3 Added 37.5%
11 $0
Q3 2023

Nov 14, 2023
BUY
N/A
8 New
8 $0

Others Institutions Holding LSTA

# of Institutions
24
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About LISATA THERAPEUTICS, INC. COMM

LSTA Quotes by TradingView
  • Ticker LSTA
More about LSTA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email